The Hierarchical Taxonomy of Psychopathology (HiTOP): A Quantitative Nosology Based on Consensus of Evidence.
Roman Kotov, Robert F Krueger, David Watson...
https://pubmed.ncbi.nlm.nih.gov/33577350/Actively Recruiting
Led by Universitair Ziekenhuis Brussel · Updated on 2024-12-09
750
Participants Needed
2
Research Sites
N/A
Total Duration
Research on personality disorders PDs in older adults is limited despite these disorders being common in this age group and often co-occurring with other mental and physical conditions. Current diagnostic criteria mainly fit younger adults, so this study evaluates new dimensional models for PDs called the Alternative Model for Personality Disorders AMPD and the ICD-11 approach. Researchers aim to assess if these models are appropriate and clinically relevant for older adults by comparing younger and older populations and studying older clinical patients. Participants include younger adults 18-64 and older adults 65 from the general population who complete questionnaires. Older adults in clinical settings with various psychological conditions will also take questionnaires, and a smaller group will undergo clinical interviews. The study uses two main questionnaires the LPFS-BF 2.0 measuring personality functioning, and the PID-5-BFM measuring personality traits. Additional standard tests and clinical ratings will be collected in the clinical population. Participants will complete questionnaires in person, with some clinical participants providing informant reports from family or friends. Researchers will analyze questionnaire results for validity, age-neutrality, and clinical utility. The primary outcomes are scores from the PID-5-BFM and LPFS-BF 2.0 collected about one month after admission, with clinical ratings and additional measures collected during hospitalization and follow-up. The study involves ongoing monitoring to understand PD structure and characteristics in older adults and improve care.
CONDITIONS
A Dimensional Model for Personality Disorders in Later Life
M
Morag Facon
G
Gina Rossi
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Universitair Ziekenhuis Brussel
Lead Sponsor
Fund for Scientific Research, Flanders, Belgium
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 1 month
Participants complete self-report and informant questionnaires to assess personality disorders and related psychopathology. Selected clinical participants undergo clinical interviews for in-depth evaluation of personality functioning and traits.
1 to 2 visits depending on assessments
Duration - Up to 1 year
Clinical participants selected for clinical ratings are followed throughout their hospitalization and study completion to assess personality disorder criteria over time.
Ongoing assessments during hospitalization and follow-up visits
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Roman Kotov, Robert F Krueger, David Watson...
https://pubmed.ncbi.nlm.nih.gov/33577350/Els Pauwels, Eva Dierckx, Dirk Smits...
https://pubmed.ncbi.nlm.nih.gov/30479806/Laura C Weekers, Joost Hutsebaut, Jan H Kamphuis
https://pubmed.ncbi.nlm.nih.gov/30230242/Bo Bach, André Kerber, Anton Aluja...
https://pubmed.ncbi.nlm.nih.gov/32369820/A Burns, A Beevor, P Lelliott...
https://pubmed.ncbi.nlm.nih.gov/10616609/S P J van Alphen, G J J A Engelen, Y Kuin...
https://pubmed.ncbi.nlm.nih.gov/16955455/C K Schotte, D de Doncker, C Vankerckhoven...
https://pubmed.ncbi.nlm.nih.gov/9794025/M K Rothbart, S A Ahadi, D E Evans
https://pubmed.ncbi.nlm.nih.gov/10653510/Roel Verheul, Helene Andrea, Caspar C Berghout...
https://pubmed.ncbi.nlm.nih.gov/18315396/André Kerber, Martin Schultze, Steffen Müller...
https://pubmed.ncbi.nlm.nih.gov/33371717/Universitair Ziekenhuis Brussel
Lead Sponsor
Fund for Scientific Research, Flanders, Belgium
Collaborating Sponsor